Heart Disease News and Research

Latest Heart Disease News and Research

Lilly, Boehringer Ingelheim announce top-line results from empagliflozin Phase III trials on T2D

Boehringer Ingelheim and Eli Lilly and Company today announced top-line results for four completed Phase III clinical trials for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT2) inhibitor being studied for treatment of patients with Type 2 Diabetes (T2D).

9 Jan 2013

Key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis

Researchers at Yale School of Medicine have identified a key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis. The study, which paves the way for developing novel targeted ovarian cancer therapies, is published online in the current issue of Cell Cycle.

9 Jan 2013

Tunisian women more likely to suffer from obesity than male compatriots

Men and women in Tunisia are not equal before the scales. Tunisian women are three times as likely to suffer from obesity as their male compatriots.

9 Jan 2013

Orexigen reports progress with FDA on faster path to Contrave NDA resubmission

Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced progress with the United States Food and Drug Administration (FDA) on a faster path to resubmission of the Contrave (naltrexone SR / bupropion SR) New Drug Application (NDA).

9 Jan 2013

Insect research yields insights for muscle control and nerve disorders in mammals

Working with fruit flies, Johns Hopkins scientists have decoded the activity of protein signals that let certain nerve cells know when and where to branch so that they reach and connect to their correct muscle targets. The proteins' mammalian counterparts are known to have signaling roles in immunity, nervous system and heart development, and tumor progression, suggesting broad implications for human disease research.

9 Jan 2013

People from low socio-economic positions in Britain eat more salt than the well off

People from low socio-economic positions in Britain eat more salt than the well off, irrespective of where they live, states a paper led by Warwick Medical School published on Tuesday in the BMJ Open journal .

9 Jan 2013

Study demonstrates effects of obesity on 'Taupathies'

In France, more than 860,000 people suffer from Alzheimer's disease and related disorders, making them the largest cause of age-related loss of intellectual function. Cognitive impairments observed in Alzheimer's disease result from the accumulation of abnormal tau proteins in nerve cells undergoing degeneration . We know that obesity, a major risk factor in the development of insulin resistance and type 2 diabetes, increases the risk of dementia during the aging process.

9 Jan 2013

Fertility window research uncovers miscarriage mechanism

Research in animals has shed light on how recurrent miscarriage is related to a dysregulation of the monthly “fertility window.”

8 Jan 2013

Asthma linked to pulmonary embolism risk

Patients with asthma have an increased risk for pulmonary embolism, show Dutch findings.

8 Jan 2013

Arterial elasticity link to lung function

People with reduced arterial elasticity may have impaired lung function, and vice versa, say US researchers.

8 Jan 2013

Lifting the burden of vascular disease

African-American men could improve their vascular health by lifting weights, researchers say.

8 Jan 2013

Laryngopharyngeal surgery option for outpatients

Laryngopharyngeal surgeries that are performed in an ambulatory setting demonstrate low complication and admission rates, suggesting that such procedures can be carried out safely on an outpatient basis, show findings from a US study.

8 Jan 2013

Impulsivity increased in euthymic mood disorder patients

Results from a US study show that patients with mood disorders exhibit increased levels of impulsivity, even during periods of euthymia.

8 Jan 2013

Trauma, infection link with stroke seen in children

Research shows that trauma and acute infection are significant risk factors for arterial ischemic stroke in children.

8 Jan 2013

Contingency management benefits drug-dependent mental health patients

Contingency management significantly reduces stimulant drug use in dependent patients with serious mental illnesses, researchers report.

8 Jan 2013

Genomic and cellular solutions to be featured by Beckman Coulter Life Sciences at SLAS2013

Bringing together genomic and cellular sample preparation with integrated solutions to highlight their Automation with a Human Touch theme.

From Beckman Coulter Life Sciences - Automation and Genomics 8 Jan 2013

Esperion reports positive results from ETC-1002 Phase 2 clinical trial on type 2 diabetes

Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, today announced positive results of a recently completed Phase 2 clinical trial of ETC-1002 in patients with type 2 diabetes with LDL-C lowering of up to 43% compared to placebo.

8 Jan 2013

Thoratec to start REVIVE-IT study using HeartMate II Left Ventricular Assist System

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that the U.S. Food and Drug Administration has granted an Investigational Device Exemption to commence the REVIVE-IT study utilizing the HeartMate II Left Ventricular Assist System.

8 Jan 2013

State roundup: Mo. lawmakers look to cap malpractice awards

A selection of health policy stories from California, Minnesota, Missouri, New York, Texas, Illinois and North Carolina.

8 Jan 2013

Spectrum Pharmaceuticals reveals positive RenaZorb Phase 1 clinical trial results

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced positive, statistically significant data from the Company's Phase 1 clinical trial evaluating the safety and tolerability of RenaZorb (also referred to as SPI-014) in healthy volunteers.

8 Jan 2013

Heart Disease News and Research

Latest Heart Disease News and Research

Lilly, Boehringer Ingelheim announce top-line results from empagliflozin Phase III trials on T2D

Key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis

Tunisian women more likely to suffer from obesity than male compatriots

Orexigen reports progress with FDA on faster path to Contrave NDA resubmission

Insect research yields insights for muscle control and nerve disorders in mammals

People from low socio-economic positions in Britain eat more salt than the well off

Study demonstrates effects of obesity on 'Taupathies'

Fertility window research uncovers miscarriage mechanism

Asthma linked to pulmonary embolism risk

Arterial elasticity link to lung function

Lifting the burden of vascular disease

Laryngopharyngeal surgery option for outpatients

Impulsivity increased in euthymic mood disorder patients

Trauma, infection link with stroke seen in children

Contingency management benefits drug-dependent mental health patients

Genomic and cellular solutions to be featured by Beckman Coulter Life Sciences at SLAS2013

Esperion reports positive results from ETC-1002 Phase 2 clinical trial on type 2 diabetes

Thoratec to start REVIVE-IT study using HeartMate II Left Ventricular Assist System

State roundup: Mo. lawmakers look to cap malpractice awards

Spectrum Pharmaceuticals reveals positive RenaZorb Phase 1 clinical trial results

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Heart Disease News and Research

Latest Heart Disease News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in